This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tanner, J. E. Articles by Panchal, C. Search for Related Content PubMed PubMed Citation Articles by Tanner, J. E. Articles by Panchal, C.

---

Angiogenesis, Metastasis, and the Cellular Microenvironment

Nucleosomes Bind Fibroblast Growth Factor-2 for Increased Angiogenesis In vitro and In vivo

¹ Laboratory of Anti-Nucleosome Antibody Therapeutics and ² Procyon Biopharma, Inc., Montreal, Quebec, Canada

Requests for reprints: Jerome E. Tanner, TanTec Biosystems, Inc., 11 Des Arbres, Dollard-des-Ormeaux, Quebec, Canada H9G 3C2. E-mail: jtanner{at}tantecbiosystems.com

Solid tumors often display sites of necrosis near regions of angiogenesis in vivo. As tumor cell necrosis would result in the release of nucleosomes into the extracellular environment, we explored the potential role of nucleosomes in the promotion of angiogenesis. Data indicate that nucleosomes acted similar to heparin and bound to several heparin-binding, proangiogenic factors [i.e., fibroblast growth factor (FGF)-1, FGF-2, vascular endothelial growth factor, and transforming growth factor-ß1]. Nucleosomes modestly enhanced FGF-2 growth of human umbilical vein endothelial cells when grown in restricted media as well as increased human umbilical vein endothelial cell migration and primitive blood vessel tube formation in vitro. On s.c. injection in mice, nucleosomes aided FGF-2 in promoting angiogenesis. These results suggest that nucleosomes released from dying tumor cells aid in the formation of blood vessels and may provide a novel means by which tumor cells increase angiogenesis.